MAPT and Alzheimer disease: We next investigated if the elevated production of Aβ1–42 led to a reliable induction of tau phosphorylation at phospho-acceptor sites whose occupancy is known to be increased in preparations of hyperphosphorylated tau from postmortem AD brains (Fig 3b).